*Klebsiella pneumoniae* is an important nosocomial pathogen involved in urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, surgical-wound infection, bacteraemia and septicaemia [@bib1], [@bib2]. It is well known that carbapenem-resistant *Enterobacteriaceae* (CRE) is a growing concern worldwide [@bib3]. In recent years, the ongoing emergence of CRE in Argentina has increased and among them, *K. pneumoniae* harbouring *K. pneumoniae* carbapenemase (KPC) are prevalent [@bib4]. KPCs are the most frequent carbapenemases found in *K. pneumoniae* and in many other members of the *Enterobacteriaceae* family such as *Escherichia coli*, *Enterobacter* spp., *Salmonella enterica*, *Proteus mirabilis* and *Citrobacter freundii* [@bib5].

Because the *bla*~KPC-2~ gene is mostly plasmid encoded [@bib6], [@bib7], [@bib8] and is typically in a Tn*3*-based transposon, Tn*4401,* the capacity of disseminating among *K. pneumoniae* and in Gram-negative genera is a major concern [@bib2], [@bib3]. *K. pneumoniae* sequence type (ST) 258 is largely responsible for KPC dissemination throughout North America and other parts of the world. No information describing *K. pneumoniae* KPC-positive isolates or KPC outbreaks in neurosurgical centres can be found in the literature. Only one report describing a KPC-2--producing *Klebsiella pneumoniae* outbreak in patients admitted to a neurosurgery department in a South Korean has been published [@bib9].

The aim of this study was to perform the molecular characterization of the genetic surroundings of the *bla*~KPC-2~ gene among *K. pneumoniae* (KPC-2 positive) clinical isolates recovered from 70 subjects tested in a neurosurgical centre in Argentina.

During 2014--2016, a total of 22 nonrepeated carbapenem-resistant *K. pneumoniae* KPC-positive isolates were recovered from a variety of samples including blood, urine and respiratory tract. Antibiotic susceptibility was determined using the VITEK 2 System (bioMérieux, Marcy l\'Etoile, France) using the panel AST-082 (GNS susceptibility card) and interpreted using the Clinical and Laboratory Standards Institute (CLSI) categories, with the exception of colistin and tigecycline, where the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommendations was used. The *bla*~KPC~ gene was identified by PCR amplification and subsequently sequenced to confirm the variant present in the isolates. The absence of other carbapenemases (*bla*~*VIM*~, *bla*~NDM-1~ and *bla*~OXA-48~) was confirmed by PCR.

Conjugation assays were performed to determine the genetic location of the gene [@bib10]. All the strains possessed similar antibiotic susceptibility profiles and harboured *bla*~KPC-2~ in conjugative plasmids ([Table 1](#tbl1){ref-type="table"}).Table 1Study strainsStrainMaterial sourceAntibiotic profile[a](#tbl1fna){ref-type="table-fn"}KPC PCRKPC 2Urine cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, COLPositiveKPC 3Urine cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositiveKPC 4Respiratory secretionMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, TIGPositiveKPC 5Blood cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, TIGPositiveKPC 6Bronchoalveolar lavageMEM, IMP, ERT, TMSPositiveKPC 8Cerebrospinal fluidMEM, IMP, ERT, TMS, CIP, FOS, COL, TIGPositiveKPC 9Urine cultureMEM, IMP, ERT, TMS, CIP, FOS, COL, TIGPositiveKPC 11Urine cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositiveKPC 13Urine cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, COL, TIGPositiveKPC 16Blood cultureMEM, IMP, ERT, TMS, CIP, FOS, COL, TIGPositiveKPC 17Urine cultureMEM, IMP, ERT, TMS, CIPPositiveKPC 18CatheterMEM, IMP, ERTPositiveKPC 19Anal swabMEM, IMP, ERT, TMS, CIPPositiveKPC 20Anal swabMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositiveKPC 21Anal swabMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositiveKPC 22Anal swabMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositiveKPC 23Anal swabMEM, IMP, ERT, TMS, CIPPositiveKPC 24CatheterMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositiveKPC 25Anal swabMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositiveKPC 26Urine cultureMEM, IMP, ERT, GEN, TMS, CIP, FOS, TIGPositiveKPC 27Respiratory secretionMEM, IMP, ERT, GEN, TMS, CIP, FOS, TIGPositive[^1][^2]

To further characterize in detail the genetic context of *bla*~KPC-2~, one strain was randomly selected (Kpn8). Plasmid extraction was performed using the QIAfilter Midi prep Kit (Qiagen, Hilden, Germany) according to the manufacturer\'s recommendations. Whole-plasmid shotgun sequencing was performed using Illumina MiSeq-I, with Nextera XT libraries for sample preparation (Illumina, San Diego, CA, USA). Assemblies were annotated by means of the RAST Server [@bib11] and the SEED source for plasmid annotations [@bib12].

The genetic analysis of the *bla*~KPC-2~ gene revealed the presence of IS*kpn6* and IS*kpn7* flanking this gene ([Fig. 1](#fig1){ref-type="fig"}). This structure was disrupting the transposon Tn*4401.* Moreover, an incomplete copy of IS*kpn31* and a part of Tn*5403* were present downstream of the later context ([Fig. 1](#fig1){ref-type="fig"}). The association between IS*kpn31* and Tn*4401* has been previously described [@bib13].Fig. 1Genetic environment of *bla*~KPC-2~ gene found in representative strain Kpn8. Transposons Tn*4001* and Tn*5403* are represented by striped square boxes; inverted repeats are shown as a grey tall line. ISs (IS*Kpn7*, IS*Kpn6* and IS*Kpn31*) are shown with striped square boxes; arrows indicate transcriptional orientation; inverted repeats are shown as a grey tall line. *bla*~KPC-2~ gene is shown by grey arrow box.

The prevalence of CRE has increased substantially during the last decade. An increased prevalence of *K. pneumoniae* ST258 harbouring KPC was observed Argentina [@bib14]. In addition, a KPC-producing *K. pneumoniae* isolate that belonged to a different ST, ST23, was also reported in the region [@bib15]. The rapid increase and dissemination of the KPC carbapenemases in centres where major surgeries take place is of great concern.

In this study we described the spread of *K. pneumoniae bla*~KPC-2~-positive strains in a neurosurgical centre. The genetic context and plasmid location of this carbapenemase has been determined. Because in all cases *bla*~KPC-2~ was plasmid located, we highlight the importance of searching for this gene and installing control measures to stop its dissemination.
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[^1]: AMK, amikacin; CIP, ciprofloxacin; COL, colistin; ERT, ertapenem; FOS, fosfomycin; GEN, gentamicin; IMP, imipenem; KPC, *Klebsiella pneumoniae* carbapenemase; MEM, meropenem; TIG, tigecycline; TMS, trimethoprim/sulfamethoxazole.

[^2]: Resistance only.
